ARQT
ARQT
US03969K1088
Arcutis Biotherapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 376.072.000 196.542.000
91.3%
Cost of Revenue 36.695.000 19.128.000
91.8%
Gross Profit 339.377.000 177.414.000
91.3%
351.604.000 305.811.000
15.0%
Operating Income -12.227.000 -128.397.000
90.5%
Pretax Income -14.970.000 -139.392.000
89.3%
Net Income Common Stockholders -16.141.000 -140.039.000
88.5%
-- --
--
-- --
--
ende